Ignite Creation Date:
2024-05-06 @ 2:28 PM
Last Modification Date:
2024-10-26 @ 1:31 PM
Study NCT ID:
NCT04323436
Status:
TERMINATED
Last Update Posted:
2024-02-06
First Post:
2020-03-23
Brief Title:
Study of Capmatinib and SpartalizumabPlacebo in Advanced NSCLC Patients With MET Exon 14 Skipping Mutations
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-08-19
Start Date Type:
ACTUAL
Primary Completion Date:
2022-12-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-01-26
Completion Date Type:
ACTUAL
First Submit Date:
2020-03-23
First Submit QC Date:
March 24 2020
Study First Post Date:
2020-03-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2024-02-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-07
Last Update Post Date:
2024-02-06
Last Update Post Date Type:
ACTUAL